Wan Qin Chong

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong et al. · Annals of Oncology · 2022 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

Soo Chin Lee, Noriko Shimasaki, Joline S.J. Lim et al. · Clinical Cancer Research · 2020 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder

Eng Hooi Tan, Andrea Li Ann Wong, Chuan Chien Tan et al. · The Breast · 2020 · 39 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)

Anthony T.�C. Chan, Victor Lee, R-L. Hong et al. · Annals of Oncology · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre

Gloria HJ Chan, Yong Xiang Gwee, Jia Li Low et al. · Lung Cancer · 2020 · 29 citations

Life Sciences, Immunology, Oncology +14